Global ePRO, E-Patient Diaries and eCOA Market

ePRO, E-Patient Diaries and eCOA Comprehensive Study by Type (ECOA (Electronic Clinical Outcome Assessments), EPROs (Patient-Reported Outcomes), ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), PerfOs (Performance Outcomes), E-Patient Diaries), Application (Contract Research Organizations, Clinical Trial Sponsors, Academic Institutes, Hospitals), Modality Type (Computer, Mobile Devices (Smartphones and Tablets)), End User (Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes, Pharmaceutical Companies, Medical Device Manufacturers) Players and Region - Global Market Outlook to 2027

ePRO, E-Patient Diaries and eCOA Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About ePRO, E-Patient Diaries and eCOA
Advancements in technology have caught up in a big way in the global healthcare industry. Doctors and healthcare professionals are seen experimenting with new and advanced instruments and are also adopting new methods of treating their patients, owing to an increase in the number of patients and mass casualties. The ePRO E-Patient Diaries and eCOA technology is an electronic patient-reported outcome that is collected by electronic devices such as smartphones, tablets, and computers. Similarly, eCOA also uses smartphones and other electronic devices to collect patient-related data. With the increase in demand for smartphones, there is also an increase in the demand for technologies such as ePRO, eCOA, etc. owing to the various inherent benefits such as elimination of data duplication, reduction in transcription errors, real-time data access, and accuracy of the data generated. These technologies have also improved patient compliance due to the provision of new apps that connect patients with doctors anytime and anywhere. The convenience offered by these technologies helps maintain user engagement as well. This software can help in connecting with multiple channels to provide enhanced communication services in healthcare hence the demand for the E-Patient Diaries and eCOA is booming.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


ePRO, E-Patient Diaries, and eCOA market, offering a comprehensive analysis of current and future market conditions of key players. The market is fragmented due to the presence of many vendors. With the growing market competition, key vendors are expected to compete on new product developments by adopting new technologies Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global ePRO, E-Patient Diaries and eCOA market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Bracket Global LLC (United States), CRF Health, Inc.(United States), ERT Clinical (United States), Medidata Solutions, Inc. (United States), ArisGlobal LLC (United States), Health Diary, Inc.( Canada), ICON plc (Ireland), PAREXEL International Corporation(United States), OmniComm Systems, Inc. (United States) and Kayentis, SAS (France) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global ePRO, E-Patient Diaries and eCOA market by Type (eCOA (Electronic Clinical Outcome Assessments), ePROs (Patient-Reported Outcomes), ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), PerfOs (Performance Outcomes) and E-Patient Diaries), Application (Contract Research Organizations, Clinical Trial Sponsors, Academic Institutes and Hospitals) and Region.



On the basis of geography, the market of ePRO, E-Patient Diaries and eCOA has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Modality Type, the sub-segment i.e. Computer will boost the ePRO, E-Patient Diaries and eCOA market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Clinical Trial Sponsors will boost the ePRO, E-Patient Diaries and eCOA market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological advancement ePRO, E-Patient Diaries, and eCOA

Market Growth Drivers:
Growth in security and privacy-related risks, The increasing demand within the global epro e-patient diaries is one of the key driving factors of growth and Due to a rise in the number of patients and mass casualties

Challenges:
Shortage of skilled professionals

Restraints:
Lack of awareness regarding ePRO, E-Patient Diaries and eCOA

Opportunities:
Increasing government support for health care expenditure




Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, ePRO, E-Patient Diaries, and eCOA Provider, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • eCOA (Electronic Clinical Outcome Assessments)
  • ePROs (Patient-Reported Outcomes)
  • ClinROs (Clinician Reported Outcomes)
  • ObsROs (Observer Reported Outcomes)
  • PerfOs (Performance Outcomes)
  • E-Patient Diaries
By Application
  • Contract Research Organizations
  • Clinical Trial Sponsors
  • Academic Institutes
  • Hospitals
By Modality Type
  • Computer
  • Mobile Devices (Smartphones and Tablets)

By End User
  • Clinical Trial Sponsors
  • Contract Research Organizations (CROs)
  • Hospitals
  • Academic Institutes
  • Pharmaceutical Companies
  • Medical Device Manufacturers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in security and privacy-related risks
      • 3.2.2. The increasing demand within the global epro e-patient diaries is one of the key driving factors of growth
      • 3.2.3. Due to a rise in the number of patients and mass casualties
    • 3.3. Market Challenges
      • 3.3.1. Shortage of skilled professionals
    • 3.4. Market Trends
      • 3.4.1. Technological advancement ePRO, E-Patient Diaries, and eCOA
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global ePRO, E-Patient Diaries and eCOA, by Type, Application, Modality Type, End User and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global ePRO, E-Patient Diaries and eCOA (Value)
      • 5.2.1. Global ePRO, E-Patient Diaries and eCOA by: Type (Value)
        • 5.2.1.1. ECOA (Electronic Clinical Outcome Assessments)
        • 5.2.1.2. EPROs (Patient-Reported Outcomes)
        • 5.2.1.3. ClinROs (Clinician Reported Outcomes)
        • 5.2.1.4. ObsROs (Observer Reported Outcomes)
        • 5.2.1.5. PerfOs (Performance Outcomes)
        • 5.2.1.6. E-Patient Diaries
      • 5.2.2. Global ePRO, E-Patient Diaries and eCOA by: Application (Value)
        • 5.2.2.1. Contract Research Organizations
        • 5.2.2.2. Clinical Trial Sponsors
        • 5.2.2.3. Academic Institutes
        • 5.2.2.4. Hospitals
      • 5.2.3. Global ePRO, E-Patient Diaries and eCOA by: Modality Type (Value)
        • 5.2.3.1. Computer
        • 5.2.3.2. Mobile Devices (Smartphones and Tablets)
      • 5.2.4. Global ePRO, E-Patient Diaries and eCOA by: End User (Value)
        • 5.2.4.1. Clinical Trial Sponsors
        • 5.2.4.2. Contract Research Organizations (CROs)
        • 5.2.4.3. Hospitals
        • 5.2.4.4. Academic Institutes
        • 5.2.4.5. Pharmaceutical Companies
        • 5.2.4.6. Medical Device Manufacturers
      • 5.2.5. Global ePRO, E-Patient Diaries and eCOA Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. ePRO, E-Patient Diaries and eCOA: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bracket Global LLC (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. CRF Health, Inc.(United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ERT Clinical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medidata Solutions, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ArisGlobal LLC (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Health Diary, Inc.( Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ICON plc (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PAREXEL International Corporation(United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. OmniComm Systems, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Kayentis, SAS (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global ePRO, E-Patient Diaries and eCOA Sale, by Type, Application, Modality Type, End User and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global ePRO, E-Patient Diaries and eCOA (Value)
      • 7.2.1. Global ePRO, E-Patient Diaries and eCOA by: Type (Value)
        • 7.2.1.1. ECOA (Electronic Clinical Outcome Assessments)
        • 7.2.1.2. EPROs (Patient-Reported Outcomes)
        • 7.2.1.3. ClinROs (Clinician Reported Outcomes)
        • 7.2.1.4. ObsROs (Observer Reported Outcomes)
        • 7.2.1.5. PerfOs (Performance Outcomes)
        • 7.2.1.6. E-Patient Diaries
      • 7.2.2. Global ePRO, E-Patient Diaries and eCOA by: Application (Value)
        • 7.2.2.1. Contract Research Organizations
        • 7.2.2.2. Clinical Trial Sponsors
        • 7.2.2.3. Academic Institutes
        • 7.2.2.4. Hospitals
      • 7.2.3. Global ePRO, E-Patient Diaries and eCOA by: Modality Type (Value)
        • 7.2.3.1. Computer
        • 7.2.3.2. Mobile Devices (Smartphones and Tablets)
      • 7.2.4. Global ePRO, E-Patient Diaries and eCOA by: End User (Value)
        • 7.2.4.1. Clinical Trial Sponsors
        • 7.2.4.2. Contract Research Organizations (CROs)
        • 7.2.4.3. Hospitals
        • 7.2.4.4. Academic Institutes
        • 7.2.4.5. Pharmaceutical Companies
        • 7.2.4.6. Medical Device Manufacturers
      • 7.2.5. Global ePRO, E-Patient Diaries and eCOA Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. ePRO, E-Patient Diaries and eCOA: by Type(USD Million)
  • Table 2. ePRO, E-Patient Diaries and eCOA ECOA (Electronic Clinical Outcome Assessments) , by Region USD Million (2016-2021)
  • Table 3. ePRO, E-Patient Diaries and eCOA EPROs (Patient-Reported Outcomes) , by Region USD Million (2016-2021)
  • Table 4. ePRO, E-Patient Diaries and eCOA ClinROs (Clinician Reported Outcomes) , by Region USD Million (2016-2021)
  • Table 5. ePRO, E-Patient Diaries and eCOA ObsROs (Observer Reported Outcomes) , by Region USD Million (2016-2021)
  • Table 6. ePRO, E-Patient Diaries and eCOA PerfOs (Performance Outcomes) , by Region USD Million (2016-2021)
  • Table 7. ePRO, E-Patient Diaries and eCOA E-Patient Diaries , by Region USD Million (2016-2021)
  • Table 8. ePRO, E-Patient Diaries and eCOA: by Application(USD Million)
  • Table 9. ePRO, E-Patient Diaries and eCOA Contract Research Organizations , by Region USD Million (2016-2021)
  • Table 10. ePRO, E-Patient Diaries and eCOA Clinical Trial Sponsors , by Region USD Million (2016-2021)
  • Table 11. ePRO, E-Patient Diaries and eCOA Academic Institutes , by Region USD Million (2016-2021)
  • Table 12. ePRO, E-Patient Diaries and eCOA Hospitals , by Region USD Million (2016-2021)
  • Table 13. ePRO, E-Patient Diaries and eCOA: by Modality Type(USD Million)
  • Table 14. ePRO, E-Patient Diaries and eCOA Computer , by Region USD Million (2016-2021)
  • Table 15. ePRO, E-Patient Diaries and eCOA Mobile Devices (Smartphones and Tablets) , by Region USD Million (2016-2021)
  • Table 16. ePRO, E-Patient Diaries and eCOA: by End User(USD Million)
  • Table 17. ePRO, E-Patient Diaries and eCOA Clinical Trial Sponsors , by Region USD Million (2016-2021)
  • Table 18. ePRO, E-Patient Diaries and eCOA Contract Research Organizations (CROs) , by Region USD Million (2016-2021)
  • Table 19. ePRO, E-Patient Diaries and eCOA Hospitals , by Region USD Million (2016-2021)
  • Table 20. ePRO, E-Patient Diaries and eCOA Academic Institutes , by Region USD Million (2016-2021)
  • Table 21. ePRO, E-Patient Diaries and eCOA Pharmaceutical Companies , by Region USD Million (2016-2021)
  • Table 22. ePRO, E-Patient Diaries and eCOA Medical Device Manufacturers , by Region USD Million (2016-2021)
  • Table 23. South America ePRO, E-Patient Diaries and eCOA, by Country USD Million (2016-2021)
  • Table 24. South America ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 25. South America ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 26. South America ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 27. South America ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 28. Brazil ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 29. Brazil ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 30. Brazil ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 31. Brazil ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 32. Argentina ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 33. Argentina ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 34. Argentina ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 35. Argentina ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 36. Rest of South America ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 37. Rest of South America ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 38. Rest of South America ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 39. Rest of South America ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 40. Asia Pacific ePRO, E-Patient Diaries and eCOA, by Country USD Million (2016-2021)
  • Table 41. Asia Pacific ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 42. Asia Pacific ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 43. Asia Pacific ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 44. Asia Pacific ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 45. China ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 46. China ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 47. China ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 48. China ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 49. Japan ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 50. Japan ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 51. Japan ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 52. Japan ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 53. India ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 54. India ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 55. India ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 56. India ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 57. South Korea ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 58. South Korea ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 59. South Korea ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 60. South Korea ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 61. Taiwan ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 62. Taiwan ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 63. Taiwan ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 64. Taiwan ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 65. Australia ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 66. Australia ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 67. Australia ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 68. Australia ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 69. Rest of Asia-Pacific ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 71. Rest of Asia-Pacific ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 72. Rest of Asia-Pacific ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 73. Europe ePRO, E-Patient Diaries and eCOA, by Country USD Million (2016-2021)
  • Table 74. Europe ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 75. Europe ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 76. Europe ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 77. Europe ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 78. Germany ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 79. Germany ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 80. Germany ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 81. Germany ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 82. France ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 83. France ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 84. France ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 85. France ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 86. Italy ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 87. Italy ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 88. Italy ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 89. Italy ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 90. United Kingdom ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 91. United Kingdom ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 92. United Kingdom ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 93. United Kingdom ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 94. Netherlands ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 95. Netherlands ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 96. Netherlands ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 97. Netherlands ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 98. Rest of Europe ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 99. Rest of Europe ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 100. Rest of Europe ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 101. Rest of Europe ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 102. MEA ePRO, E-Patient Diaries and eCOA, by Country USD Million (2016-2021)
  • Table 103. MEA ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 104. MEA ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 105. MEA ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 106. MEA ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 107. Middle East ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 108. Middle East ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 109. Middle East ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 110. Middle East ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 111. Africa ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 112. Africa ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 113. Africa ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 114. Africa ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 115. North America ePRO, E-Patient Diaries and eCOA, by Country USD Million (2016-2021)
  • Table 116. North America ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 117. North America ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 118. North America ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 119. North America ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 120. United States ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 121. United States ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 122. United States ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 123. United States ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 124. Canada ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 125. Canada ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 126. Canada ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 127. Canada ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 128. Mexico ePRO, E-Patient Diaries and eCOA, by Type USD Million (2016-2021)
  • Table 129. Mexico ePRO, E-Patient Diaries and eCOA, by Application USD Million (2016-2021)
  • Table 130. Mexico ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2016-2021)
  • Table 131. Mexico ePRO, E-Patient Diaries and eCOA, by End User USD Million (2016-2021)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. ePRO, E-Patient Diaries and eCOA: by Type(USD Million)
  • Table 143. ePRO, E-Patient Diaries and eCOA ECOA (Electronic Clinical Outcome Assessments) , by Region USD Million (2022-2027)
  • Table 144. ePRO, E-Patient Diaries and eCOA EPROs (Patient-Reported Outcomes) , by Region USD Million (2022-2027)
  • Table 145. ePRO, E-Patient Diaries and eCOA ClinROs (Clinician Reported Outcomes) , by Region USD Million (2022-2027)
  • Table 146. ePRO, E-Patient Diaries and eCOA ObsROs (Observer Reported Outcomes) , by Region USD Million (2022-2027)
  • Table 147. ePRO, E-Patient Diaries and eCOA PerfOs (Performance Outcomes) , by Region USD Million (2022-2027)
  • Table 148. ePRO, E-Patient Diaries and eCOA E-Patient Diaries , by Region USD Million (2022-2027)
  • Table 149. ePRO, E-Patient Diaries and eCOA: by Application(USD Million)
  • Table 150. ePRO, E-Patient Diaries and eCOA Contract Research Organizations , by Region USD Million (2022-2027)
  • Table 151. ePRO, E-Patient Diaries and eCOA Clinical Trial Sponsors , by Region USD Million (2022-2027)
  • Table 152. ePRO, E-Patient Diaries and eCOA Academic Institutes , by Region USD Million (2022-2027)
  • Table 153. ePRO, E-Patient Diaries and eCOA Hospitals , by Region USD Million (2022-2027)
  • Table 154. ePRO, E-Patient Diaries and eCOA: by Modality Type(USD Million)
  • Table 155. ePRO, E-Patient Diaries and eCOA Computer , by Region USD Million (2022-2027)
  • Table 156. ePRO, E-Patient Diaries and eCOA Mobile Devices (Smartphones and Tablets) , by Region USD Million (2022-2027)
  • Table 157. ePRO, E-Patient Diaries and eCOA: by End User(USD Million)
  • Table 158. ePRO, E-Patient Diaries and eCOA Clinical Trial Sponsors , by Region USD Million (2022-2027)
  • Table 159. ePRO, E-Patient Diaries and eCOA Contract Research Organizations (CROs) , by Region USD Million (2022-2027)
  • Table 160. ePRO, E-Patient Diaries and eCOA Hospitals , by Region USD Million (2022-2027)
  • Table 161. ePRO, E-Patient Diaries and eCOA Academic Institutes , by Region USD Million (2022-2027)
  • Table 162. ePRO, E-Patient Diaries and eCOA Pharmaceutical Companies , by Region USD Million (2022-2027)
  • Table 163. ePRO, E-Patient Diaries and eCOA Medical Device Manufacturers , by Region USD Million (2022-2027)
  • Table 164. South America ePRO, E-Patient Diaries and eCOA, by Country USD Million (2022-2027)
  • Table 165. South America ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 166. South America ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 167. South America ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 168. South America ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 169. Brazil ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 170. Brazil ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 171. Brazil ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 172. Brazil ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 173. Argentina ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 174. Argentina ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 175. Argentina ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 176. Argentina ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 177. Rest of South America ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 178. Rest of South America ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 179. Rest of South America ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 180. Rest of South America ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 181. Asia Pacific ePRO, E-Patient Diaries and eCOA, by Country USD Million (2022-2027)
  • Table 182. Asia Pacific ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 183. Asia Pacific ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 184. Asia Pacific ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 185. Asia Pacific ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 186. China ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 187. China ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 188. China ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 189. China ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 190. Japan ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 191. Japan ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 192. Japan ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 193. Japan ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 194. India ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 195. India ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 196. India ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 197. India ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 198. South Korea ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 199. South Korea ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 200. South Korea ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 201. South Korea ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 202. Taiwan ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 203. Taiwan ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 204. Taiwan ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 205. Taiwan ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 206. Australia ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 207. Australia ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 208. Australia ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 209. Australia ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 210. Rest of Asia-Pacific ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 211. Rest of Asia-Pacific ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 212. Rest of Asia-Pacific ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 213. Rest of Asia-Pacific ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 214. Europe ePRO, E-Patient Diaries and eCOA, by Country USD Million (2022-2027)
  • Table 215. Europe ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 216. Europe ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 217. Europe ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 218. Europe ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 219. Germany ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 220. Germany ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 221. Germany ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 222. Germany ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 223. France ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 224. France ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 225. France ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 226. France ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 227. Italy ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 228. Italy ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 229. Italy ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 230. Italy ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 231. United Kingdom ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 232. United Kingdom ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 233. United Kingdom ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 234. United Kingdom ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 235. Netherlands ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 236. Netherlands ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 237. Netherlands ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 238. Netherlands ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 239. Rest of Europe ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 240. Rest of Europe ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 241. Rest of Europe ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 242. Rest of Europe ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 243. MEA ePRO, E-Patient Diaries and eCOA, by Country USD Million (2022-2027)
  • Table 244. MEA ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 245. MEA ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 246. MEA ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 247. MEA ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 248. Middle East ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 249. Middle East ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 250. Middle East ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 251. Middle East ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 252. Africa ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 253. Africa ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 254. Africa ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 255. Africa ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 256. North America ePRO, E-Patient Diaries and eCOA, by Country USD Million (2022-2027)
  • Table 257. North America ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 258. North America ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 259. North America ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 260. North America ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 261. United States ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 262. United States ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 263. United States ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 264. United States ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 265. Canada ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 266. Canada ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 267. Canada ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 268. Canada ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 269. Mexico ePRO, E-Patient Diaries and eCOA, by Type USD Million (2022-2027)
  • Table 270. Mexico ePRO, E-Patient Diaries and eCOA, by Application USD Million (2022-2027)
  • Table 271. Mexico ePRO, E-Patient Diaries and eCOA, by Modality Type USD Million (2022-2027)
  • Table 272. Mexico ePRO, E-Patient Diaries and eCOA, by End User USD Million (2022-2027)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global ePRO, E-Patient Diaries and eCOA: by Type USD Million (2016-2021)
  • Figure 5. Global ePRO, E-Patient Diaries and eCOA: by Application USD Million (2016-2021)
  • Figure 6. Global ePRO, E-Patient Diaries and eCOA: by Modality Type USD Million (2016-2021)
  • Figure 7. Global ePRO, E-Patient Diaries and eCOA: by End User USD Million (2016-2021)
  • Figure 8. South America ePRO, E-Patient Diaries and eCOA Share (%), by Country
  • Figure 9. Asia Pacific ePRO, E-Patient Diaries and eCOA Share (%), by Country
  • Figure 10. Europe ePRO, E-Patient Diaries and eCOA Share (%), by Country
  • Figure 11. MEA ePRO, E-Patient Diaries and eCOA Share (%), by Country
  • Figure 12. North America ePRO, E-Patient Diaries and eCOA Share (%), by Country
  • Figure 13. Global ePRO, E-Patient Diaries and eCOA share by Players 2021 (%)
  • Figure 14. Global ePRO, E-Patient Diaries and eCOA share by Players (Top 3) 2021(%)
  • Figure 15. Global ePRO, E-Patient Diaries and eCOA share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bracket Global LLC (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bracket Global LLC (United States) Revenue: by Geography 2021
  • Figure 19. CRF Health, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 20. CRF Health, Inc.(United States) Revenue: by Geography 2021
  • Figure 21. ERT Clinical (United States) Revenue, Net Income and Gross profit
  • Figure 22. ERT Clinical (United States) Revenue: by Geography 2021
  • Figure 23. Medidata Solutions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Medidata Solutions, Inc. (United States) Revenue: by Geography 2021
  • Figure 25. ArisGlobal LLC (United States) Revenue, Net Income and Gross profit
  • Figure 26. ArisGlobal LLC (United States) Revenue: by Geography 2021
  • Figure 27. Health Diary, Inc.( Canada) Revenue, Net Income and Gross profit
  • Figure 28. Health Diary, Inc.( Canada) Revenue: by Geography 2021
  • Figure 29. ICON plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. ICON plc (Ireland) Revenue: by Geography 2021
  • Figure 31. PAREXEL International Corporation(United States) Revenue, Net Income and Gross profit
  • Figure 32. PAREXEL International Corporation(United States) Revenue: by Geography 2021
  • Figure 33. OmniComm Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. OmniComm Systems, Inc. (United States) Revenue: by Geography 2021
  • Figure 35. Kayentis, SAS (France) Revenue, Net Income and Gross profit
  • Figure 36. Kayentis, SAS (France) Revenue: by Geography 2021
  • Figure 37. Global ePRO, E-Patient Diaries and eCOA: by Type USD Million (2022-2027)
  • Figure 38. Global ePRO, E-Patient Diaries and eCOA: by Application USD Million (2022-2027)
  • Figure 39. Global ePRO, E-Patient Diaries and eCOA: by Modality Type USD Million (2022-2027)
  • Figure 40. Global ePRO, E-Patient Diaries and eCOA: by End User USD Million (2022-2027)
  • Figure 41. South America ePRO, E-Patient Diaries and eCOA Share (%), by Country
  • Figure 42. Asia Pacific ePRO, E-Patient Diaries and eCOA Share (%), by Country
  • Figure 43. Europe ePRO, E-Patient Diaries and eCOA Share (%), by Country
  • Figure 44. MEA ePRO, E-Patient Diaries and eCOA Share (%), by Country
  • Figure 45. North America ePRO, E-Patient Diaries and eCOA Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bracket Global LLC (United States)
  • CRF Health, Inc.(United States)
  • ERT Clinical (United States)
  • Medidata Solutions, Inc. (United States)
  • ArisGlobal LLC (United States)
  • Health Diary, Inc.( Canada)
  • ICON plc (Ireland)
  • PAREXEL International Corporation(United States)
  • OmniComm Systems, Inc. (United States)
  • Kayentis, SAS (France)
Select User Access Type

Key Highlights of Report


Nov 2022 240 Pages 80 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global ePRO, E-Patient Diaries and eCOA Market Quantitative research analysis
Global ePRO, E-Patient Diaries and eCOA Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Bracket Global LLC (United States), CRF Health, Inc.(United States), ERT Clinical (United States), Medidata Solutions, Inc. (United States), ArisGlobal LLC (United States), Health Diary, Inc.( Canada), ICON plc (Ireland), PAREXEL International Corporation(United States), OmniComm Systems, Inc. (United States) and Kayentis, SAS (France) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological advancement ePRO, E-Patient Diaries, and eCOA" is seen as one of major influencing trends for ePRO, E-Patient Diaries and eCOA Market during projected period 2021-2027.
The ePRO, E-Patient Diaries and eCOA market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global ePRO, E-Patient Diaries and eCOA Market Report?

Have a Query? Click Here

Other Related Reports

Blockchain Technology in Transportation and Logistics Comprehensive Study by Type (Software, Service), Organization Size (Small & Medium-Sized Enterprises, Large Enterprises), Blockchain Type (Public...
$ 3450
Big Data Technology & Services Comprehensive Study by Deployment Mode (On-Premises, Cloud/On-Demand), Industries (BFSI, Retail, Aerospace and Defense, Media and Entertainment, Healthcare and Pharmace...
$ 3750
Blockchain In Genomics Comprehensive Study by Type (Public, Federated, Private), Application (Clinical Trials, IP Management, Drug Discovery, Data storage and security, Others), Target (B2B, B2C, C2C...
$ 3650
Augmented Intelligence Comprehensive Study by End-users (IT and Telecommunication, Retail and E-Commerce, BFSI, Healthcare, Others), Technology (Machine Learning, Natural Language Processing, Context...
$ 3450
Beacons Technology Comprehensive Study by Connectivity (Bluetooth Low Energy (BLE), Hybrid), Industry Verticals (Retail, Public Gatherings & Spaces, Hospitality, Transportation & Logistics, Sports, ...
$ 3750
Digitalization in logistics Comprehensive Study by Application (Warehouse Management, Labor Management, Transportation Management, Others), Service/Solutions Type (Solution (Asset Management, Warehou...
$ 3750